Literature DB >> 7539429

Interferon-induced MxA protein. GTP binding and GTP hydrolysis properties.

M F Richter1, M Schwemmle, C Herrmann, A Wittinghofer, P Staeheli.   

Abstract

MxA is a GTPase encoded by an interferon-activated human gene which inhibits the multiplication of several RNA viruses. Recombinant histidine-tagged MxA protein (His-MxA) was expressed in Escherichia coli and purified to near homogeneity. Gel filtration showed that it formed high molecular weight oligomers. Purified His-MxA exhibited specific GTP hydrolysis rates of up to 350 nmol of GTP/min/mg of protein, corresponding to a turnover number of 27 min-1. The Km for this reaction was 260 microM. Guanine nucleotides did not copurify with His-MxA. Binding experiments in solution with fluorescent-labeled nucleotides confirmed that His-MxA binds guanine nucleotides rather weakly and further showed that the fluorescent GDP analog N-methylanthraniloyl (mant)-GDP had a much lower affinity for His-MxA (Kd 20 microM, koff 8.5 s-1) than the nonhydrolyzable GTP analog mant-5'-guanylyl-beta,gamma-imidotriphosphate (mant-GMP-PNP) (Kd 0.75 microM, koff 0.012 s-1). Competitive binding studies with nonlabeled nucleotides revealed a similar binding preference of His-MxA for GTP over GDP: the Kd for GTP was 20 microM, whereas the Kd for GDP was 100 microM. Thus, a high percentage of MxA molecules may be complexed with GTP in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539429

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  A monomeric GTPase-negative MxA mutant with antiviral activity.

Authors:  C Janzen; G Kochs; O Haller
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Mx is dispensable for interferon-mediated resistance of chicken cells against influenza A virus.

Authors:  Benjamin Schusser; Antje Reuter; Alexander von der Malsburg; Nicola Penski; Steffen Weigend; Bernd Kaspers; Peter Staeheli; Sonja Härtle
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

3.  Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome.

Authors:  Kadir Turan; Masaki Mibayashi; Kenji Sugiyama; Shoko Saito; Akiko Numajiri; Kyosuke Nagata
Journal:  Nucleic Acids Res       Date:  2004-01-29       Impact factor: 16.971

4.  An assembly-incompetent mutant establishes a requirement for dynamin self-assembly in clathrin-mediated endocytosis in vivo.

Authors:  Byeong Doo Song; Defne Yarar; Sandra L Schmid
Journal:  Mol Biol Cell       Date:  2004-03-05       Impact factor: 4.138

5.  Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids.

Authors:  G Kochs; O Haller
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

Review 6.  Dynamin-like MxA GTPase: structural insights into oligomerization and implications for antiviral activity.

Authors:  Otto Haller; Song Gao; Alexander von der Malsburg; Oliver Daumke; Georg Kochs
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

Review 7.  Mx proteins: antiviral gatekeepers that restrain the uninvited.

Authors:  Judith Verhelst; Paco Hulpiau; Xavier Saelens
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

8.  The myxovirus resistance A (MxA) gene -88G>T single nucleotide polymorphism is associated with prostate cancer.

Authors:  Shanora Glymph; Sanjay Mandal; Ashley Evans Knowell; Fisseha Abebe; Jaideep Chaudhary
Journal:  Infect Genet Evol       Date:  2013-02-22       Impact factor: 3.342

9.  Antiviral determinants of rat Mx GTPases map to the carboxy-terminal half.

Authors:  L Johannes; R Kambadur; H Lee-Hellmich; C A Hodgkinson; H Arnheiter; E Meier
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

10.  Positive regulation of humoral and innate immune responses induced by inactivated Avian Influenza Virus vaccine in broiler chickens.

Authors:  Fatma Abdallah; Ola Hassanin
Journal:  Vet Res Commun       Date:  2015-09-02       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.